80 related articles for article (PubMed ID: 34154624)
1. An MR-based radiomics model for differentiation between hepatocellular carcinoma and focal nodular hyperplasia in non-cirrhotic liver.
Ding Z; Lin K; Fu J; Huang Q; Fang G; Tang Y; You W; Lin Z; Lin Z; Pan X; Zeng Y
World J Surg Oncol; 2021 Jun; 19(1):181. PubMed ID: 34154624
[TBL] [Abstract][Full Text] [Related]
2. A combined model based on radiomics features of Sonazoid contrast-enhanced ultrasound in the Kupffer phase for the diagnosis of well-differentiated hepatocellular carcinoma and atypical focal liver lesions: a prospective, multicenter study.
Wang Z; Yao J; Jing X; Li K; Lu S; Yang H; Ding H; Li K; Cheng W; He G; Jiang T; Liu F; Yu J; Han Z; Cheng Z; Tan S; Wang Z; Qi E; Wang S; Zhang Y; Li L; Dong X; Liang P; Yu X
Abdom Radiol (NY); 2024 May; ():. PubMed ID: 38744698
[TBL] [Abstract][Full Text] [Related]
3. MRI radiomics to monitor therapeutic outcome of sorafenib plus IHA transcatheter NK cell combination therapy in hepatocellular carcinoma.
Yu G; Zhang Z; Eresen A; Hou Q; Garcia EE; Yu Z; Abi-Jaoudeh N; Yaghmai V; Zhang Z
J Transl Med; 2024 Jan; 22(1):76. PubMed ID: 38243292
[TBL] [Abstract][Full Text] [Related]
4. Automated Assessment of T2-Weighted MRI to Differentiate Malignant and Benign Primary Solid Liver Lesions in Noncirrhotic Livers Using Radiomics.
Starmans MPA; Miclea RL; Vilgrain V; Ronot M; Purcell Y; Verbeek J; Niessen WJ; Ijzermans JNM; de Man RA; Doukas M; Klein S; Thomeer MG
Acad Radiol; 2024 Mar; 31(3):870-879. PubMed ID: 37648580
[TBL] [Abstract][Full Text] [Related]
5. Editorial for "Deep Learning Radiomics Model of Dynamic Contrast-Enhanced MRI for Evaluating Vessels Encapsulating Tumor Clusters and Prognosis in Hepatocellular Carcinoma".
Chernyak V
J Magn Reson Imaging; 2024 Jan; 59(1):120-121. PubMed ID: 37165916
[No Abstract] [Full Text] [Related]
6. Letter to the Editor: radiomics-based distinction of small (≤ 2 cm) hepatocellular carcinoma and precancerous lesions based on unenhanced magnetic imaging resonance.
Hu Z; Tian Z; Wei X; Chen Y
Clin Radiol; 2024 Mar; ():. PubMed ID: 38631932
[No Abstract] [Full Text] [Related]
7. Radiomics Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma from Hepatocellular Carcinoma: A Multi-Center Study.
Guo L; Li X; Zhang C; Xu Y; Han L; Zhang L
J Hepatocell Carcinoma; 2023; 10():795-806. PubMed ID: 37288140
[TBL] [Abstract][Full Text] [Related]
8. Radiomics Analysis on Noncontrast CT for Distinguishing Hepatic Hemangioma (HH) and Hepatocellular Carcinoma (HCC).
Hu S; Lyu X; Li W; Cui X; Liu Q; Xu X; Wang J; Chen L; Zhang X; Yin Y
Contrast Media Mol Imaging; 2022; 2022():7693631. PubMed ID: 35833080
[TBL] [Abstract][Full Text] [Related]
9. MRI-Based Radiomics Models to Discriminate Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma in LR-M According to LI-RADS Version 2018.
Zhang H; Guo D; Liu H; He X; Qiao X; Liu X; Liu Y; Zhou J; Zhou Z; Liu X; Fang Z
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626199
[TBL] [Abstract][Full Text] [Related]
10. MRI-based radiomics distinguish different pathological types of hepatocellular carcinoma.
Wang X; Wang S; Yin X; Zheng Y
Comput Biol Med; 2022 Feb; 141():105058. PubMed ID: 34836622
[TBL] [Abstract][Full Text] [Related]
11. Radiomics Based on Contrast-Enhanced MRI in Differentiation Between Fat-Poor Angiomyolipoma and Hepatocellular Carcinoma in Noncirrhotic Liver: A Multicenter Analysis.
Zhao X; Zhou Y; Zhang Y; Han L; Mao L; Yu Y; Li X; Zeng M; Wang M; Liu Z
Front Oncol; 2021; 11():744756. PubMed ID: 34722300
[TBL] [Abstract][Full Text] [Related]
12. A Radiomics Approach to Predict the Emergence of New Hepatocellular Carcinoma in Computed Tomography for High-Risk Patients with Liver Cirrhosis.
Tietz E; Truhn D; Müller-Franzes G; Berres ML; Hamesch K; Lang SA; Kuhl CK; Bruners P; Schulze-Hagen M
Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34573991
[TBL] [Abstract][Full Text] [Related]
13. Precision of MRI radiomics features in the liver and hepatocellular carcinoma.
Carbonell G; Kennedy P; Bane O; Kirmani A; El Homsi M; Stocker D; Said D; Mukherjee P; Gevaert O; Lewis S; Hectors S; Taouli B
Eur Radiol; 2022 Mar; 32(3):2030-2040. PubMed ID: 34564745
[TBL] [Abstract][Full Text] [Related]
14. Research on multi-model imaging machine learning for distinguishing early hepatocellular carcinoma.
Ma Y; Gong Y; Qiu Q; Ma C; Yu S
BMC Cancer; 2024 Mar; 24(1):363. PubMed ID: 38515051
[TBL] [Abstract][Full Text] [Related]
15. Current status of magnetic resonance imaging radiomics in hepatocellular carcinoma: A quantitative review with Radiomics Quality Score.
Brancato V; Cerrone M; Garbino N; Salvatore M; Cavaliere C
World J Gastroenterol; 2024 Jan; 30(4):381-417. PubMed ID: 38313230
[TBL] [Abstract][Full Text] [Related]
16. Radiomics in CT and MR imaging of the liver and pancreas: tools with potential for clinical application.
Berbís MÁ; Godino FP; Rodríguez-Comas J; Nava E; García-Figueiras R; Baleato-González S; Luna A
Abdom Radiol (NY); 2024 Jan; 49(1):322-340. PubMed ID: 37889265
[TBL] [Abstract][Full Text] [Related]
17. Development and validation a radiomics nomogram for predicting thymidylate synthase status in hepatocellular carcinoma based on Gd-DTPA contrast enhanced MRI.
Ding Z; Wu Y; Fang G; Lin Z; Lin K; Fu J; Huang Q; Tang Y; You W; Liu J; Zeng Y
BMC Cancer; 2023 Oct; 23(1):991. PubMed ID: 37848807
[TBL] [Abstract][Full Text] [Related]
18. Focal Lesions of the Liver and Radiomics: What Do We Know?
Anichini M; Galluzzo A; Danti G; Grazzini G; Pradella S; Treballi F; Bicci E
Diagnostics (Basel); 2023 Aug; 13(15):. PubMed ID: 37568954
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
